The response to anti-PD1 therapy depends on the expression of CXCR3 ligands by dendritic cells in the tumour, which promote the proliferation and activation of intratumoural CD8+ T cells.
引用
收藏
页码:414 / 415
页数:1
相关论文
共 1 条
[1]
Chow MT(2019)Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy Immunity undefined undefined-undefined
Chow MT(2019)Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy Immunity undefined undefined-undefined